The most important substance is the physiological "switch" of the erection.
How long can erection last?
As long as sexual stimulation of the brain continues and a sufficiently high concentration of active cyclic quanosine monophosphate (cGMP) is maintained. Unfortunately, this substance readily goes into its inactive form - the usual quanosine monophosphate (GNP). It is physiologically switched off by a constant enzyme type 5 phosphodiesterase
The type 5 phosphodiesterase (PDE 5) enzyme is a physiological "erection" switch.
As we remember - the erection initiates a cascade of psychic and biochemical reactions ending with an increase in the chemical concentration of the "switch" of the cyclic quanosine monophosphate. In a healthy man, there is a dynamic balance between this psycho-physiological process that allows erection and the activity of the "disabling" enzyme. In erectile dysfunction, biochemical erection stimulators (nitric oxide, guanilate cyclase, active cyclic quanosine monophosphate) are usually too small, and their inactivation (exclusion) by the exclusion enzyme works well unless we block the enzyme!
What happens if we block the physiological "erection" switch?
The blockage of the enzyme that disables the erection causes that even the temporary "production" of nitric oxide by erotic nerve stimulated by excitement is sufficient to achieve the proper concentration of the penicillary muscle relaxant - the active cyclic quanosine monophosphate (cGMP). Importantly, the high concentration of this substance - cGMP - can last quite long even without further supply of nitric oxide. In this situation, men with the above-mentioned organic erectile dysfunctions have an erection opportunity, i.e. close to 80% of patients visiting the doctor.
Erythromycin blockers - phosphodiesterase type 5 inhibitors (PDE 5 inhibitors)
That's how it happened - help for men with erectile dysfunction comes with drugs that block the enzyme that blocks the erection. These are the phosphodiesterase type 5 inhibitors already mentioned (PDE5 inhibitors)